Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Regulatory Document Services In Europe
4 services found
Manufactured by:BCN Peptides S.A. based inSant Quintí de Mediona, SPAIN
BCN Peptides brings together a legacy of experience in successfully managing the complex regulatory and registration processes required for peptides. In addition to compiling and submitting regulatory documents for pharmaceutical substances in Europe, US and Japan, BCN Peptides also has extensive regulatory experience ...
by:Ergomed based inSurrey, UNITED KINGDOM
Global regulatory framework assessment tool. This heat-map assesses the suitability of the country's regulatory framework based on your protocol. Simply enter details of your trial design to see which countries will facilitate fast approval and which ones will be more challenging. The fastest countries will be colored the darkest, more challenging the lightest and white where it's not possible. ...
by:HAPILA GmbH based inGera, GERMANY
HAPILA GmbH is a company with many years of tradition in the synthesis and development of active ingredients. We have accompanied our partners from the idea on paper to clinical phase III for almost two decades. Some of our long-standing business partners still supply the market with medicines made from HAPILA active ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Natural killer (NK) cells are innate lymphocytes that kill virally infected or malignant cells. Unlike T cells, NK cells function in an antigen independent manner, responding to anything they perceive as "non-self", including malignant cells. NK cells are an attractive allogeneic immune modulator, as they have a well-known safety profile and lack the potential to cause graft-vs-host disease, a ...